Pyrazinamide News and Research

RSS
ACTG announces launch of clinical trial evaluating a three-month TB treatment

ACTG announces launch of clinical trial evaluating a three-month TB treatment

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

WHO welcomes SHINE trial results on shorter treatment for drug-susceptible TB in children

WHO welcomes SHINE trial results on shorter treatment for drug-susceptible TB in children

New approach to identify faster, more effective TB drug treatment regimens

New approach to identify faster, more effective TB drug treatment regimens

Novel models and strategies for TB detection, elimination, and care

Novel models and strategies for TB detection, elimination, and care

Anti-TB drugs can increase susceptibility to Mtb reinfection

Anti-TB drugs can increase susceptibility to Mtb reinfection

Peptide derived from fungi prevents growth of tuberculosis bacteria

Peptide derived from fungi prevents growth of tuberculosis bacteria

Researchers use new methods to optimize treatments for tuberculosis meningitis

Researchers use new methods to optimize treatments for tuberculosis meningitis

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Researchers tackling deadly TB discuss the way forward in treatment and prevention

Researchers tackling deadly TB discuss the way forward in treatment and prevention

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Treating multidrug-resistant tuberculosis with regimens may improve outcomes

Treating multidrug-resistant tuberculosis with regimens may improve outcomes

TB Alliance receives Australian DFAT grant to support late-stage clinical trials of new TB drugs

TB Alliance receives Australian DFAT grant to support late-stage clinical trials of new TB drugs

PaMZ drug regimen shows potential to improve treatment for MDR-TB

PaMZ drug regimen shows potential to improve treatment for MDR-TB

Eating food just before taking TB drug could reduce effectiveness of medicine

Eating food just before taking TB drug could reduce effectiveness of medicine

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria